Kenvue Inc. (KVUE) to Distribute Quarterly Dividend of $0.21 on October 2nd

Kenvue Inc. (NYSE:KVUEGet Free Report) announced a quarterly dividend on Thursday, September 10th. Stockholders of record on Monday, September 21st will be given a dividend of 0.21 per share on Friday, October 2nd. This represents a c) dividend on an annualized basis and a dividend yield of 4.7%. The ex-dividend date is Monday, September 21st.

Kenvue has a dividend payout ratio of 68.9% meaning its dividend is sufficiently covered by earnings. Equities analysts expect Kenvue to earn $1.23 per share next year, which means the company should continue to be able to cover its $0.84 annual dividend with an expected future payout ratio of 68.3%.

Kenvue Price Performance

KVUE opened at $17.73 on Friday. The company has a fifty day simple moving average of $19.05 and a 200 day simple moving average of $18.24. The firm has a market cap of $34.06 billion, a price-to-earnings ratio of 20.39, a PEG ratio of 1.59 and a beta of 0.46. Kenvue has a twelve month low of $14.02 and a twelve month high of $20.13. The company has a current ratio of 1.01, a quick ratio of 0.71 and a debt-to-equity ratio of 0.67.

Kenvue (NYSE:KVUEGet Free Report) last issued its quarterly earnings data on Thursday, August 6th. The company reported $0.31 EPS for the quarter, missing analysts’ consensus estimates of $0.32 by ($0.01). Kenvue had a return on equity of 21.22% and a net margin of 10.76%.The firm had revenue of $3.96 billion during the quarter, compared to analyst estimates of $3.97 billion. During the same quarter in the prior year, the firm earned $0.29 EPS. The business’s quarterly revenue was up 3.0% compared to the same quarter last year. Equities research analysts expect that Kenvue will post 1.14 EPS for the current fiscal year.

About Kenvue

(Get Free Report)

Kenvue Inc is a global consumer health company that develops, markets and sells products designed to support everyday health and personal care. Its portfolio spans over-the-counter medicines, skin health and beauty, essential health products, and baby and family care.

The company’s brands include Tylenol, Motrin, Zyrtec and Benadryl in self-care; Neutrogena, Aveeno and Clean & Clear in skin health and beauty; Listerine in oral care; and Johnson’s and Band-Aid in baby care and essential health.

See Also

Dividend History for Kenvue (NYSE:KVUE)

Receive News & Ratings for Kenvue Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Kenvue and related companies with MarketBeat.com's FREE daily email newsletter.